Cargando…
SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
Hybrid immunity occurs in those who have been both infected with and vaccinated against SARS-CoV-2. But how well does such hybrid immunity protect against the virus and its emerging variants?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362961/ https://www.ncbi.nlm.nih.gov/pubmed/35945353 http://dx.doi.org/10.1038/s41577-022-00771-8 |
| _version_ | 1784764824100536320 |
|---|---|
| author | Suryawanshi, Rahul Ott, Melanie |
| author_facet | Suryawanshi, Rahul Ott, Melanie |
| author_sort | Suryawanshi, Rahul |
| collection | PubMed |
| description | Hybrid immunity occurs in those who have been both infected with and vaccinated against SARS-CoV-2. But how well does such hybrid immunity protect against the virus and its emerging variants? |
| format | Online Article Text |
| id | pubmed-9362961 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93629612022-08-10 SARS-CoV-2 hybrid immunity: silver bullet or silver lining? Suryawanshi, Rahul Ott, Melanie Nat Rev Immunol Comment Hybrid immunity occurs in those who have been both infected with and vaccinated against SARS-CoV-2. But how well does such hybrid immunity protect against the virus and its emerging variants? Nature Publishing Group UK 2022-08-09 2022 /pmc/articles/PMC9362961/ /pubmed/35945353 http://dx.doi.org/10.1038/s41577-022-00771-8 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Comment Suryawanshi, Rahul Ott, Melanie SARS-CoV-2 hybrid immunity: silver bullet or silver lining? |
| title | SARS-CoV-2 hybrid immunity: silver bullet or silver lining? |
| title_full | SARS-CoV-2 hybrid immunity: silver bullet or silver lining? |
| title_fullStr | SARS-CoV-2 hybrid immunity: silver bullet or silver lining? |
| title_full_unstemmed | SARS-CoV-2 hybrid immunity: silver bullet or silver lining? |
| title_short | SARS-CoV-2 hybrid immunity: silver bullet or silver lining? |
| title_sort | sars-cov-2 hybrid immunity: silver bullet or silver lining? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362961/ https://www.ncbi.nlm.nih.gov/pubmed/35945353 http://dx.doi.org/10.1038/s41577-022-00771-8 |
| work_keys_str_mv | AT suryawanshirahul sarscov2hybridimmunitysilverbulletorsilverlining AT ottmelanie sarscov2hybridimmunitysilverbulletorsilverlining |